May 30 |
Gilead's Trodelvy misses primary endpoint in phase 3 bladder cancer trial
|
May 30 |
Gilead Provides Update on Phase 3 TROPiCS-04 Study
|
May 29 |
Buy Low, Hold Long: 2 Crushed Dividend Stocks To Buy For High Yields And Long-Term Gains
|
May 29 |
Gilead and Cartography enter deal to develop cancer therapies
|
May 28 |
Gilead Sciences: Seriously Undervalued At Peak Pessimism
|
May 28 |
Gilead partnering with Cartography Biosciences to discover cancer therapies
|
May 28 |
Gilead Sciences Partners With White House for Early Cancer Detection Program "Biden Cancer Moonshot"
|
May 28 |
2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years
|
May 27 |
Gilead Sciences: Disappointing Fundamentals And Sentiment, But Still Bullish
|
May 27 |
Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows
|